Zoetis (ZTS) Accounts Payables (2012 - 2026)
Zoetis' (ZTS) quarterly Accounts Payables came in at $452.0 million in Q2 2026, down 11.02% year-over-year from $508.0 million in Q2 2025, and down 10.85% quarter-over-quarter from $507.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Accounts Payables (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Accounts Payables for 15 consecutive years, with $452.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Accounts Payables fell 11.02% year-over-year to $452.0 million in Q2 2026; TTM through Jun 2026 was $452.0 million, a 11.02% decrease from a year earlier, with the FY2025 full-year figure at $445.0 million, up 2.77% from the prior year.
- Accounts Payables was $452.0 million for Q2 2026 at Zoetis, down from $507.0 million in the prior quarter.
- Over five years, Accounts Payables peaked at $508.0 million in Q2 2025 and troughed at $373.0 million in Q3 2022.
- A 5-year average of $427.8 million and a median of $420.0 million in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables gained 20.95% in 2025 and decreased 11.02% in 2026, its largest moves.
- Over 5 years, Accounts Payables stood at $405.0 million in 2022, then rose by 1.48% to $411.0 million in 2023, then advanced by 5.35% to $433.0 million in 2024, then climbed by 2.77% to $445.0 million in 2025, then gained by 1.57% to $452.0 million in 2026.
- The last three Accounts Payables figures came in at $452.0 million (Q2 2026), $507.0 million (Q1 2026), and $445.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 129.10 Mn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 452.00 Mn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 427.00 Mn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 127.31 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | 2.81 Mn |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | 6.21 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 175.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 452.00 Mn |
| Mar 31, 2026 | 507.00 Mn |
| Dec 31, 2025 | 445.00 Mn |
| Sep 30, 2025 | 410.00 Mn |
| Jun 30, 2025 | 508.00 Mn |
| Mar 31, 2025 | 420.00 Mn |
| Dec 31, 2024 | 433.00 Mn |
| Sep 30, 2024 | 404.00 Mn |
| Jun 30, 2024 | 420.00 Mn |
| Mar 31, 2024 | 405.00 Mn |
| Dec 31, 2023 | 411.00 Mn |
| Sep 30, 2023 | 388.00 Mn |
| Jun 30, 2023 | 464.00 Mn |
| Mar 31, 2023 | 424.00 Mn |
| Dec 31, 2022 | 405.00 Mn |
| Sep 30, 2022 | 373.00 Mn |
| Jun 30, 2022 | 430.00 Mn |
| Mar 31, 2022 | 402.00 Mn |
| Dec 31, 2021 | 436.00 Mn |
| Sep 30, 2021 | 387.00 Mn |